Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study
- PMID: 17631431
- DOI: 10.1016/j.ijsu.2007.05.009
Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study
Abstract
Background: The pre-operative staging in oesophageal cancer is often challenging and underestimation of the extent of the disease may lead to unnecessary surgery.
Aim: To audit the use and assess the value of fluorine-18 fluorodeoxyglucose positron emission tomography ((18)F FDG-PET) as a staging tool for thoracic oesophageal and gastro-oesophageal junction (GOJ) cancers in our oncological surgical practice.
Patients and methods: Over a 3 year period, between 2002 and 2004, 134 patients with thoracic oesophageal or GOJ cancer were referred to our unit for treatment. The standard preoperative staging investigation in all cases was CT (thorax, abdomen and pelvis). A preoperative FDG-PET scan was further requested in 22 patients. The case notes of all the patients that underwent a FDG-PET scan were reviewed and compared with the preoperative imaging, the operative findings and the histopathology of the resected tumours.
Results: Eighteen men and 4 women with a median age of 65 (range 43-79) years were studied. After FDG-PET, 13 out of 22 patients (59%) were deemed suitable for tumour resection. Twelve of the 13 patients were fit to undergo surgery. At laparotomy, 2 of those (17%) were found inoperable due to widespread disease. The sensitivity of CT versus FDG-PET to detect infiltrated lymph nodes was 29% (95% CI: 3-70) versus 71% (95% CI: 29-96) (P=0.0412), whereas both tests had 67% specificity (95% CI: 9-99) in detecting lymph nodes. The sensitivity and the specificity of CT versus FDG-PET to detect distant organ metastases (M1b) were 33% (95% CI: 4-77) and 88% (95% CI: 47-99) versus 50% (95% CI: 6-93) and 100% (95% CI: 69-100), respectively (P>0.05). The FDG-PET regarding the N and M status differed from the CT in 11 patients and led to modification of the planned management in 5 of them.
Conclusions: FDG-PET is more accurate than CT in defining N and M status. It can result in a reduction of unnecessary surgery in a significant number of patients. The combined PET-CT scan as a single imaging modality is expected to further improve diagnostic accuracy of FDG-PET.
Similar articles
-
[Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].Chirurg. 2003 Oct;74(10):922-30; discussion 929-30. doi: 10.1007/s00104-003-0711-x. Chirurg. 2003. PMID: 14605734 German.
-
Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.Clin Radiol. 2008 Jul;63(7):765-73. doi: 10.1016/j.crad.2008.02.002. Epub 2008 Apr 11. Clin Radiol. 2008. PMID: 18555034
-
Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13. Scand J Urol Nephrol. 2011. PMID: 21231796
-
Role of positron emission tomography in the (re-)staging of oesophageal cancer.Scand J Gastroenterol Suppl. 2006;(243):116-22. doi: 10.1080/00365520600664409. Scand J Gastroenterol Suppl. 2006. PMID: 16782630 Review.
-
Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review.Abdom Imaging. 2008 Mar-Apr;33(2):183-90. doi: 10.1007/s00261-007-9241-1. Abdom Imaging. 2008. PMID: 17619927 Review.
Cited by
-
Update: modern approaches to the treatment of localized esophageal cancer.Curr Oncol Rep. 2011 Jun;13(3):157-67. doi: 10.1007/s11912-011-0158-z. Curr Oncol Rep. 2011. PMID: 21365188 Free PMC article.
-
FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer.Int J Clin Oncol. 2019 Aug;24(8):927-933. doi: 10.1007/s10147-019-01428-8. Epub 2019 Mar 12. Int J Clin Oncol. 2019. PMID: 30863993
-
Oesophageal cancer: can imaging improve its assessment?Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1921-7. doi: 10.1007/s00259-008-0884-0. Eur J Nucl Med Mol Imaging. 2008. PMID: 18682938 No abstract available.
-
Can hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.Int J Clin Oncol. 2009 Oct;14(5):421-5. doi: 10.1007/s10147-009-0893-4. Epub 2009 Oct 25. Int J Clin Oncol. 2009. PMID: 19856050
-
The early use of PET-CT alters the management of patients with esophageal cancer.J Gastrointest Surg. 2009 May;13(5):868-73. doi: 10.1007/s11605-009-0812-z. Epub 2009 Jan 28. J Gastrointest Surg. 2009. PMID: 19184245 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical